Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Clinical trial NCT00180895 · TERMINATED
Trial details
- NCT number
- NCT00180895
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.